Argentina Respiratory Devices Market

Argentina Respiratory Devices Market Analysis

The Argentina Respiratory Devices Market size is estimated at USD 210.88 million in 2025, and is expected to reach USD 274.57 million by 2030, at a CAGR of 5.42% during the forecast period (2025-2030).

The prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), tuberculosis (TB), asthma, and sleep apnea, coupled with technological advancements and a large patient population, is driving market growth in Argentina. For instance, according to a report published by the Revista Americana de Medicina Respiratoria in February 2022, the prevalence of COPD in Argentina's urban general population was 14.3%. The presence of a large patient pool suggested that between 2.5 and 3 million patients are living with COPD in Argentina.

High healthcare R&D expenditures and the import of medical devices in the country are anticipated to increase the adoption of respiratory devices, fostering market growth. For instance, according to the International Trade Association, in 2024, healthcare spending in Argentina accounted for about 9-10% of GDP in 2022, and medical equipment and device imports made up approximately 70-75% of the total import market, with local manufacturing covering the remainder. Therefore, the high healthcare expenditures and significant import of medical devices and equipment are anticipated to increase the expenditure on chronic diseases such as asthma and COPD, thereby driving market growth.

The rising elderly population in the country is anticipated to increase the adoption of respiratory devices, as this age group is more prone to respiratory diseases. For instance, according to the Pan American Health Organization, individuals aged 65 and over made up 12.1% of the total population in 2023.

Therefore, the rising incidence of respiratory diseases, a rise in research and development expenditures, and an increase in the geriatric population are factors anticipated to boost market growth. However, the high cost of devices is expected to hamper market growth.

Argentina Respiratory Devices Market Trends

Inhalers in Therapeutic Devices are Estimated to Witness Healthy Growth in the Future

The therapeutic devices segment is expected to experience robust growth during the forecast period due to the increasing prevalence of respiratory disorders, a growing patient population with chronic diseases, and a rising geriatric population.

Therapeutic devices such as inhalers are essential for managing respiratory disorders. The availability of reimbursement coverage and the rising number of asthma patients in Argentina support market growth.

According to a study published in the Official Journal of the Asian Pacific Society of Respirology in November 2023, severe asthma (SA) in Argentina was estimated to affect over 1.6 million individuals. Notably, 31% of patients attending specialized asthma centers were diagnosed with asthma according to the ATS/ERS guidelines, with a significant 64.1% failing to achieve adequate disease control. Therefore, such a huge prevalence of chronic respiratory conditions such as asthma is anticipated to increase the adoption of respiratory therapeutic devices such as inhalers, boosting the segment’s growth.

Thus, the increasing efficacy and tolerability of monoclonal antibody drugs, rising product approvals, and research and development activities by market players are expected to drive the growth of this segment over the forecast period.

Sleep Test Devices in Diagnostic and Monitoring Devices are Anticipated to Record Significant Growth Over the Forecast Period

Sleep test devices, also known as sleep monitors or trackers, are essential for diagnosing and monitoring sleep disorders such as sleep apnea and insomnia. These devices range from simple wearable trackers to sophisticated medical-grade equipment used in sleep studies.

The high prevalence of sleep disorders in the country is anticipated to increase the adoption of sleep devices, boosting the segment’s growth. For instance, according to the study published in the Journal of Allergy and Clinical Immunology in February 2024, intermediate and high-risk obstructive sleep apnea (OSA) accounted for 54% of cases, while insomnia followed closely at 33% in Argentina. Therefore, the high prevalence of OSA is anticipated to increase the number of sleep monitoring devices such as CPAP machines, thereby boosting segmental growth.

Furthermore, according to a study published by Universidad Favaloro in March 2023, 75% of the population in Argentina had some type of sleep disorder. Therefore, the high prevalence of sleep disorders in the country is anticipated to increase the adoption of sleep testing devices for the detection of quality sleep in patients, thereby boosting the segment's growth.

Thus, the rising number of sleep disorders such as obstructive sleep apnea and insomnia is anticipated to increase the demand for sleep testing devices in the country, thereby boosting the segment's growth.

Argentina Respiratory Devices Industry Overview

The respiratory devices market in Argentina is semi-consolidated, with several players operating in it. This can be attributed to significant investments in research and development activities by major players in the market. These investments aim to gain a competitive advantage over rivals by launching technologically advanced products. Some of the players operating in the market include Drägerwerk AG & Co. KGaA, Tecme SA, ResMed, Medtronic, and GE Healthcare.

Argentina Respiratory Devices Market Leaders

Argentina Respiratory Devices Market News

• April 2024: The Ministry of Health, Argentina, launched the Winter Campaign under the Program for Acute Respiratory Infections. This initiative aims to treat and prevent these diseases, which pose a significant risk to children. The campaign is especially important during the colder months when there is a seasonal increase in the demand for medical care.
• June 2023: Argentina launched its national campaign for open, free, and voluntary asthma detection. Leading this initiative, the Argentine Association of Patients with Asthma (AAPA) partnered up with the Argentine Association of Allergy and Clinical Immunology (AAAeIC), the Argentine Association of Respiratory Medicine (AAMR), the NOA GANOA Asthma Group, and Asthma Right Care Argentina. Together, they drove the first National Asthma Detection Campaign in the country.